Seizure Engram
Seizure Engram
批准号:
10304392
负责人:
ROBERT E GROSS
金额:
$3.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-15 至 2021-10-31
关键词:
AcuteAdverse effectsAffectAnimalsBehaviorBiologicalBrainBrain regionCellsChemicalsChimeric ProteinsChronicControl AnimalDiseaseElectric StimulationEngineeringEnterobacteria phage P1 Cre recombinaseEpilepsyExhibitsFOS geneFire - disastersFluorescenceFluorescence MicroscopyGene ExpressionGeneralized seizuresGenerationsGenesGeneticGenetic RecombinationGoalsHippocampus (Brain)HistologicImmediate-Early GenesInjectionsInterventionIntractable EpilepsyKnowledgeLabelLightLuciferasesMemoryMolecularMusNeuronsOperative Surgical ProceduresOpsinPatientsPentylenetetrazolePharmaceutical PreparationsPopulationPreventionProceduresProcessProteinsPumpReagentReporterRodentRodent ModelSeizuresStereotypingStructureSystemTamoxifenTechniquesTestingTimeTransgenic MiceViral Vectorbasebrain cellcell typecoelenterazinecomparative efficacydentate gyruseffective therapygranule cellinnovationmouse modelneuroregulationoptogeneticspreventpromotersuccesstool
中文摘要
项目摘要/摘要
癫痫发作的特征是整个大脑中神经元的协调和同步活动
一段较长的时间。我们假设,与其他正常的大脑控制行为一样,癫痫发作
不是由神经元的随机活动引起的,而是由特定的、有组织的大脑网络中的活动引起的。
我们的首要目标是阐明大脑中这种癫痫特异的网络,并将基因
神经调节专门针对这种癫痫发作产生网络,以进行量身定制的癫痫发作抑制。在我们的
建议,我们首先确定构成急、慢性啮齿动物癫痫发作网络的所有关键脑细胞
癫痫模型。然后,我们将操纵这样的网络来阻止癫痫的发生。
我们将识别和可视化在整个大脑中导致癫痫发作的大脑结构和细胞
通过利用复杂的基因表达技术用荧光蛋白标签标记这些细胞
转基因小鼠(特定目标1)。当神经元表现出癫痫发作的特异性标记时,就会出现这种标记
在癫痫发作期间,系统中存在化学物质时的广泛活动。这个贴标签的程序
将重复检查相同的神经元群体是否在两个不同的发作中变得活跃
癫痫发作。标记有荧光报告的细胞将在荧光显微镜下进行检查。
两次癫痫发作之间神经元的重叠标记将支持我们的假设,即相同的子集
神经元反复参与癫痫发作的发生。
然后,我们将采用类似的策略,将遗传神经调节传递给癫痫发作产生网络
(具体目标2)。我们设计了一种病毒载体,它携带一种分子工具,当
一种激活剂被注射到动物体内。这种病毒载体将被注射到负责
我们将在癫痫的啮齿类动物模型中使用癫痫的产生。我们预计,这种操纵将
抑制随后的癫痫发作。
我们的假说将癫痫发作视为大脑中的一种网络功能。与强大的
网络特异性抑制癫痫小鼠模型的发作,这将改变我们看待和
治疗这种疾病。
英文摘要
PROJECT SUMMARY/ABSTRACT
Epileptic seizures can be characterized as concerted and synchronized activity of neurons across the brain for
an extended period of time. We hypothesize that, as for other normal brain-controlled behavior, epileptic seizures
are not caused by random activity of neurons, but rather arise from activity in a specific, organized brain network.
Our overarching goal is to elucidate such a seizure-specific network in the brain and to deliver genetic
neuromodulation specifically to such a seizure-generating network for tailored seizure suppression. In our
proposal, we first identify all the critical brain cells that make up that seizure network in acute and chronic rodent
models of epilepsy. Then, we will manipulate such a network to stop seizure occurrence.
We will identify and visualize brain structures and cells responsible for generation of seizures in the whole brain
by labeling these cells with a fluorescent protein tag utilizing sophisticated gene expression techniques in
genetically modified mice (Specific Aim 1). This seizure-specific labelling of neurons occurs when they exhibit
extensive activity in the presence of a chemical in the system during a seizure episode. This labelling procedure
will be repeated to examine if the same neuronal populations become active in two separate episodes of
seizures. The cells labeled with the fluorescence reporter will be examined by fluorescence microscopy.
Overlapped labelling of neurons between two seizure episodes will support our hypothesis that the same subset
of neurons is repeatedly involved in generation of seizures.
We will then employ a similar strategy to deliver genetic neuromodulation to a seizure-generating network
(Specific Aim 2). We engineered a viral vector that carries a molecular tool that suppress neuronal activity when
an activating drug is injected into the animal. This viral vector will be injected into a brain region responsible for
generation of seizures in the rodent models of epilepsy we will use. We expect that such manipulation will
suppress subsequent seizures.
Our hypothesis views and treats epileptic seizures as a network function in the brain. Together with robust
network-specific suppression of seizures in mouse models of epilepsy, this will change the way we view and
treat this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and validation of a viral vector for targeted inhibition of DG granule cells
-
批准号:10648833
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2023
-
负责人:ROBERT E GROSS
-
依托单位:
Data-driven optimization for DBS programming in temporal lobe epilepsy
-
批准号:10574839
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2022
-
负责人:ROBERT E GROSS
-
依托单位:
Medical Scientist Training Program
-
批准号:10706808
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2022
-
负责人:ROBERT E GROSS
-
依托单位:
Medical Scientist Training Program
-
批准号:10658566
-
项目类别:
-
资助金额:$5.7万
-
财政年份:2022
-
负责人:ROBERT E GROSS
-
依托单位:
Medical Scientist Training Program
-
批准号:10270489
-
项目类别:
-
资助金额:$125.48万
-
财政年份:2022
-
负责人:ROBERT E GROSS
-
依托单位:
Medical Scientist Training Program
-
批准号:10875319
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2022
-
负责人:ROBERT E GROSS
-
依托单位:
Medical Scientist Training Program
-
批准号:10650705
-
项目类别:
-
资助金额:$127.72万
-
财政年份:2022
-
负责人:ROBERT E GROSS
-
依托单位:
Seizure Engram
-
批准号:9979524
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2020
-
负责人:ROBERT E GROSS
-
依托单位:
Development of a self-regulated neuroprotective gene therapy for Parkinsons Disease and other synucleinopathies
-
批准号:9809188
-
项目类别:
-
资助金额:$42.54万
-
财政年份:2019
-
负责人:ROBERT E GROSS
-
依托单位:
C3 transferase Gene Therapy for CNS Axon Regeneration
-
批准号:8873702
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2015
-
负责人:ROBERT E GROSS
-
依托单位:
Application of optogenetics in iPS cell transplantation therapy for ischemic stro
-
批准号:9067533
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:ROBERT E GROSS
-
依托单位:
Application of optogenetics in iPS cell transplantation therapy for ischemic stro
-
批准号:8918754
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:ROBERT E GROSS
-
依托单位:
Application of optogenetics in iPS cell transplantation therapy for ischemic stro
-
批准号:8830148
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2014
-
负责人:ROBERT E GROSS
-
依托单位:
Autonomous Optogenetic Inhibition of Epileptic Activity Using a Bioluminescent Li
-
批准号:8624726
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2012
-
负责人:ROBERT E GROSS
-
依托单位:
Autonomous Optogenetic Inhibition of Epileptic Activity Using a Bioluminescent Li
-
批准号:8464291
-
项目类别:
-
资助金额:$29.21万
-
财政年份:2012
-
负责人:ROBERT E GROSS
-
依托单位:
Autonomous Optogenetic Inhibition of Epileptic Activity Using a Bioluminescent Li
-
批准号:8583198
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2012
-
负责人:ROBERT E GROSS
-
依托单位:
Autonomous Optogenetic Inhibition of Epileptic Activity Using a Bioluminescent Li
-
批准号:8333799
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2012
-
负责人:ROBERT E GROSS
-
依托单位:
Distributed microstimulation for epilepsy
-
批准号:7667763
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2008
-
负责人:ROBERT E GROSS
-
依托单位:
Distributed microstimulation for epilepsy
-
批准号:7532610
-
项目类别:
-
资助金额:$20.35万
-
财政年份:2008
-
负责人:ROBERT E GROSS
-
依托单位:
Axon Guidance Molecules in Nigrostriatal Regeneration
-
批准号:7112340
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2004
-
负责人:ROBERT E GROSS
-
依托单位:
海外基金